Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a model...
Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
In 2022, the World Health Organization extended their guidelines for perennial malaria chemoprevention (PMC) from infants to children up to 24 months old. However, evidence for PMC’s public health impact is primarily limited to children under 15 months. Further research is needed to assess the public health impact and cost-effectiveness of PMC, and...
Alternative Titles
Full title
Public health impact of current and proposed age-expanded perennial malaria chemoprevention: a modelling study
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_b0d04afeb9274aeba69c3a07a84bf4b6
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_b0d04afeb9274aeba69c3a07a84bf4b6
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-025-93623-z
